- Home
- CNTX vs LTRX Comparison
CNTX vs LTRX Comparison
Compare CNTX & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- LTRX
- Stock Information
- Founded
- CNTX 2015
- LTRX 1989
- Country
- CNTX United States
- LTRX United States
- Employees
- CNTX N/A
- LTRX N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- LTRX Computer Communications Equipment
- Sector
- CNTX Health Care
- LTRX Telecommunications
- Exchange
- CNTX Nasdaq
- LTRX Nasdaq
- Market Cap
- CNTX 78.0M
- LTRX 85.6M
- IPO Year
- CNTX 2021
- LTRX 2000
- Fundamental
- Price
- CNTX $0.65
- LTRX $2.79
- Analyst Decision
- CNTX Strong Buy
- LTRX Strong Buy
- Analyst Count
- CNTX 5
- LTRX 4
- Target Price
- CNTX $5.50
- LTRX $4.13
- AVG Volume (30 Days)
- CNTX 330.3K
- LTRX 297.4K
- Earning Date
- CNTX 08-06-2025
- LTRX 05-08-2025
- Dividend Yield
- CNTX N/A
- LTRX N/A
- EPS Growth
- CNTX N/A
- LTRX N/A
- EPS
- CNTX N/A
- LTRX N/A
- Revenue
- CNTX N/A
- LTRX $143,159,000.00
- Revenue This Year
- CNTX N/A
- LTRX N/A
- Revenue Next Year
- CNTX N/A
- LTRX $3.61
- P/E Ratio
- CNTX N/A
- LTRX N/A
- Revenue Growth
- CNTX N/A
- LTRX N/A
- 52 Week Low
- CNTX $0.49
- LTRX $1.91
- 52 Week High
- CNTX $2.75
- LTRX $4.55
- Technical
- Relative Strength Index (RSI)
- CNTX 51.44
- LTRX 63.02
- Support Level
- CNTX $0.62
- LTRX $2.43
- Resistance Level
- CNTX $0.70
- LTRX $3.06
- Average True Range (ATR)
- CNTX 0.04
- LTRX 0.15
- MACD
- CNTX 0.01
- LTRX 0.04
- Stochastic Oscillator
- CNTX 67.29
- LTRX 65.75
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.